Advanced Immune Therapeutic strategies (ait strategies) is a privately held firm focusing on biomedical research and development with a special interest in immunotherapeutics.
AIT Strategies believes that the immune system in individuals has the capacity to detect and eliminate cancer; however, in most clinical presentations, this capacity has proven to be immobilized or is by-passed by factors induced by the malignancy.
Our goal is to facilitate development of novel cancer therapeutics and synergistic combinations that enhance specific immunity for the potential benefit of all those touched by cancer. It is becoming widely accepted that combination therapies will be necessary to successfully mobilize the immunotherapeutic treatment of cancer and to maintain immune responses induced by cancer immunotherapies.
We work with multiple technology platforms designed to stimulate specific immunity including monoclonal antibodies, adjuvant and vaccine approaches. We collaborate with academic researchers and other immunology or cancer therapy companies. Several main areas of focus are noted: